135 related articles for article (PubMed ID: 149657)
41. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
[TBL] [Abstract][Full Text] [Related]
42. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
Bok RA; Mangel WF
Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
[TBL] [Abstract][Full Text] [Related]
43. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
[TBL] [Abstract][Full Text] [Related]
44. The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin.
Edy J; Collen D
Biochim Biophys Acta; 1977 Oct; 484(2):423-32. PubMed ID: 143966
[TBL] [Abstract][Full Text] [Related]
45. Changes in antiplasmin and plasmin activities during extreme hemodilution and open heart surgery in dogs.
Aasen AO; Gallimore MJ; Lilleaasen P; Lyngaas K; Larsbraaten M; Amundsen E
Eur Surg Res; 1979; 11(3):145-53. PubMed ID: 159822
[TBL] [Abstract][Full Text] [Related]
46. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
Hunt JA; Petteway SR; Scuderi P; Novokhatny V
Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
[TBL] [Abstract][Full Text] [Related]
47. Studies on the mechanism of binding of serpins and serine proteases.
Longstaff C; Gaffney PJ
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):89-97. PubMed ID: 1377955
[TBL] [Abstract][Full Text] [Related]
48. Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin.
Hortin GL; Gibson BL; Fok KF
Biochem Biophys Res Commun; 1988 Sep; 155(2):591-6. PubMed ID: 2458720
[TBL] [Abstract][Full Text] [Related]
49. Hydrodynamic studies on the streptokinase complexes of human plasminogen, Val442-plasminogen, plasmin, and the plasmin-derived light (B) chain.
Barlow GH; Summaria L; Robbins KC
Biochemistry; 1984 May; 23(11):2384-7. PubMed ID: 6236844
[TBL] [Abstract][Full Text] [Related]
50. Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus.
Broeseker TA; Boyle MD; Lottenberg R
Microb Pathog; 1988 Jul; 5(1):19-27. PubMed ID: 2977421
[TBL] [Abstract][Full Text] [Related]
51. The suitability of various plasmin preparations for the functional assay of alpha 2-antiplasmin in plasma.
Kluft C; Traas DW; Jie AF; Hoegee-de Nobel E
Thromb Haemost; 1982 Dec; 48(3):320-4. PubMed ID: 6219471
[TBL] [Abstract][Full Text] [Related]
52. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
Kramer MD; Reinartz J
J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
[TBL] [Abstract][Full Text] [Related]
53. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand.
Kuusela P; Saksela O
Eur J Biochem; 1990 Nov; 193(3):759-65. PubMed ID: 1701146
[TBL] [Abstract][Full Text] [Related]
54. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe.
Miles LA; Plow EF
Biochemistry; 1986 Nov; 25(22):6926-33. PubMed ID: 3099830
[TBL] [Abstract][Full Text] [Related]
55. Fibrinolysis and fibrinogenolysis by Val442-plasmin.
Ney KA; Pizzo SV
Biochim Biophys Acta; 1982 Nov; 708(2):218-24. PubMed ID: 6216916
[TBL] [Abstract][Full Text] [Related]
56. [Kinetics of in vitro fibrinolysis by plasmin and a plasmin-streptokinase equimolar complex].
Aĭsina RB; Zhitkova IuV; Eremeev NL; Popova GIu; Kazanskaia NF
Ukr Biokhim Zh (1978); 1991; 63(1):20-6. PubMed ID: 1827551
[TBL] [Abstract][Full Text] [Related]
57. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
[TBL] [Abstract][Full Text] [Related]
58. Plasmin's peptide-binding specificity: characterization of ligand sites in alpha 2-antiplasmin.
Hortin GL; Trimpe BL; Fok KF
Thromb Res; 1989 Jun; 54(6):621-32. PubMed ID: 2551057
[TBL] [Abstract][Full Text] [Related]
59. Stimulation of plasmin activity by oleic acid.
Higazi AA; Finci-Yeheskel Z; Samara AA; Aziza R; Mayer M
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):863-6. PubMed ID: 1532491
[TBL] [Abstract][Full Text] [Related]
60. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
Plow EF; Freaney DE; Plescia J; Miles LA
J Cell Biol; 1986 Dec; 103(6 Pt 1):2411-20. PubMed ID: 3023400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
